Table 3 Baseline characteristics of HBV/C. sinensis co-infection group and HBV or C. sinensis mono-infection groups.

From: High prevalence of Clonorchis sinensis infections and coinfection with hepatitis virus in riverside villages in northeast China

 

Hepatitis C (n = 59)

HCV/C. sinensis coinfection (n = 59)

C. sinensis (n = 59)

P1

P2

Age (years, mean ± SD)

57.78 ± 7.91

57.54 ± 8.47

57.46 ± 8.33

0.876

0.956

Sex (Male, %)

46 (78.0)

46 (78.0)

46 (78.0)

1.000

1.000

ALT (IU/mL)

54.0 (41.0, 81.0)

62.0 (42.0, 103.0)

38.0 (31.0, 48.0)

0.236

 < 0.001

AST (IU/mL)

45.0 (32.0, 67.0)

54.0 (38.0, 87.0)

28.0 (24.0, 35.0)

0.052

 < 0.001

Total protein (g/L)

78.0 (72.0, 85.0)

79.0 (75.0, 85.0)

77.0 (72.0, 82.0)

0.292

0.031

ALB (g/L)

43.0 (41.0, 45.0)

43.0 (42.0, 45.0)

44.0 (42.0, 46.0)

0.184

0.539

ALB/GLB

1.22 (1.07, 1.43)

1.18 (1.09, 1.35)

1.36 (1.23, 1.53)

0.51

0.001

TBIL (µmol/L)

17.0 (12.0, 22.0)

19.0 (14.0, 24.0)

16.0 (13.0, 20.0)

0.164

0.036

IBIL (µmol/L)

10.0 (6.0, 13.0)

11.0 (7.0, 15.0)

9.0 (6.0, 12.0)

0.111

0.025

GGT (U/L)

53.0 (29.0, 104.0)

69.0 (37.0, 143.0)

36.0 (25.0, 69.0)

0.114

0.001

ALP (U/L)

73.0 (61.0, 93.0)

78.0 (61.0, 93.0)

70.0 (56.0, 81.0)

0.577

0.035

Creatinine (ÎĽmol/L)

65.0 (58.0, 73.0)

65.0 (56.0, 75.0)

66.0 (58.0, 74.0)

0.732

0.724

BUN (mmol/L)

5.5 (4.5, 6.6)

5.80 (4.60, 6.60)

5.5 (4.8, 6.2)

0.628

0.554

Uric acid (µmol/L)

363.0 (330.0, 404.0)

377.0 (315.0, 424.0)

365.0 (305.0, 438.0)

0.317

0.844

TG (mmol/L)

1.38 (0.85, 1.73)

1.28 (0.89, 2.04)

1.54 (1.19, 2.54)

0.861

0.020

Cholesterol (mmol/L)

3.30 (2.80, 3.70)

3.30 (2.90, 4.00)

3.80 (3.20, 4.40)

0.425

0.003

LDL (mmol/L)

1.22 (0.91, 1.68)

1.27 (0.87, 1.77)

1.66 (1.16, 2.23)

0.998

0.011

GLU (mmol/L)

3.85 (3.53, 4.05)

4.10 (3.60, 4.40)

3.70 (3.35, 6.48)

0.377

0.535

WBC (*109/L)

6.28 (4.82, 7.73)

6.02 (5.12, 7.30)

6.81 (5.83, 8.09)

0.72

0.012

RBC (*1,012/L)

4.49 (4.28, 4.97)

4.57 (4.18, 4.93)

4.64 (4.34, 4.85)

0.901

0.825

PLT (*109/L)

144.0 (102.0, 179.0)

136.0 (106.0, 176.0)

180.0 (147.0, 215.0)

0.677

 < 0.001

Lymphocyte (*109/L)

2.12 (1.73, 2.68)

2.00 (1.73, 2.49)

2.30 (1.97, 2.53)

0.62

0.029

Neutrophil (*109/L)

3.28 (2.29, 4.66)

3.30 (2.63, 4.03)

3.62 (2.88, 4.40)

0.733

0.039

Eosinophil count (*109/L)

0.15 (0.09, 0.20)

0.17 (0.11, 0.28)

0.25 (0.16, 0.47)

0.177

0.004

Haemoglobin (g/L)

152.0 (144.0, 161.0)

153.0 (142.0, 164.0)

153.0 (145.0, 161.0)

0.784

0.981

lg (HCV-RNA)

6.43 (5.71, 6.92)

6.27 (5.49, 6.82)

–

0.587

–

HCV-Genotype (1b, %)

32 (54.2)

27 (45.8)

–

0.361

–

APRI

0.74 (0.49, 1.47)

0.88 (0.55, 1.88)

0.35 (0.28, 0.52)

0.156

 < 0.001

FIB-4

2.54 (1.65, 4.22)

3.01 (1.93, 5.39)

1.52 (1.18, 2.08)

0.188

 < 0.001

  1. ALT alanine aminotransferase, AST aspartate aminotransferase, ALB albumin, GLB globulin, ALB/GLB albumin to globulin, TBIL total bilirubin, IBIL indirect bilirubin, GGT gamma-glutamyl transpeptidase, ALP alkaline phosphatase, BUN blood urea nitrogen, TG triglyceride, LDL low-density lipoprotein, GLU glucose, WBC white blood cell, RBC red blood cell, PLT platelet, APRI, levels and AST to PLT ratio index, FIB-4 fibrosis-4 scores.
Back to article page